EUVIMEDEUVIMED entdecken
Crossref

Salvianolic Acid B Promotes Placental and Decidual Angiogenesis by Restoring the Normal Expression of Hypoxia‐Inducible Factor‐1α/Vascular Endothelial Growth Factor in Mice With Recurrent Pregnancy Loss

Fangfang Hu, Chao Yang, Lujun Dai, Dan Gao, Heng Luo, Xingming Zhong, Panpan Chen, Leilei Zhu, Ziwen Xiao, Shuyun Zhao, Guanyou Huang

American Journal of Reproductive Immunology · 2025

DOI: 10.1111/aji.70105 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Reproductive Immunology, 2025. Verfasst von Fangfang Hu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Medicine Center, Department of Obstetrics and Gynecology, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China. Hauptthemen laut MEDLINE: Hypoxia-Inducible Factor 1, alpha Subunit, Placenta, Vascular Endothelial Growth Factor A, Abortion, Habitual. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: National Natural Science Foundation of China presided over by Guanyou Huang and Shuyun Zhao, Program of Guizhou Medical University for applying National Natural Science Foundation presided over by Guanyou Huang.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Accumulating evidence suggests the association between abnormal angiogenesis at the maternal–fetal interface and recurrent pregnancy loss (RPL); nonetheless, the mechanism remains largely unknown. Previous studies have reported the clinical effect of the traditional Chinese medicine Danshen in the treatment of RPL. This study aimed to investigate whether salvianolic acid B (SalB), the primary water‐soluble component of Danshen, could reduce the embryonic absorption rate (EAR) by increasing placental and decidual angiogenesis in RPL mice and to explore the possible mechanism.

Methods

The decidual and chorionic tissues were collected from normal pregnancies and unknown recurrent pregnancy loss (URPL) patients. Western blotting was used to determine the expression of vascular endothelial growth factor (VEGF) and hypoxia‐inducible factor‐1α (HIF‐1α) in the tissues. Different doses of SalB and/or the VEGF inhibitor PTC299 were intragastrically administered to normal and RPL pregnant mice daily at 0.5 day of pregnancy for 10 days. The EAR, mean placental weight (MPW), and micro vessel density (MVD) were determined in placental and decidual tissues, and the number of live pups per litter was counted. The expression of VEGF and HIF‐1α in the tissues was evaluated using western blotting and immunohistochemistry.

Results

The VEGF protein levels in decidual and chorionic tissues were significantly lower, and HIF‐1α levels were significantly higher than that of normal pregnancies. The EAR was significantly higher, MVD, MPW, and protein levels of VEGF in the placental and decidual tissues of RPL mice were significantly lower than those in normal mice. In contrast, the protein levels of HIF‐1α were significantly higher in RPL mice than in normal mice. SalB restored the morphological changes in the uterus of RPL mice, as well as the number of blood vessels in the placenta and decidua, and ameliorated adverse embryonic development in mice (such as neural tube defects and reduced crown‐rump length), thereby increasing the pups per. Additionally, SalB increased the VEGF/VEGFR2/p‐VEGFR2 levels, placental and decidual MVD, and MPW and decreased the HIF‐1α levels and EAR in a dose‐dependent manner. A positive association of daily SalB dose (0–100 mg/kg) with the VEGF levels, placental and decidual MVD and MPW, and a negative association of daily SalB dose with the HIF‐1α levels and EAR were observed.PTC299 reversed the aforementioned increases and decreases in the daily SalB intake of RPL mice. Among these, the daily dose of 100 mg/kg of SalB was deemed optimal, and a daily dose of SalB exceeding 100 mg/kg did not entirely induce these changes. No correlation between HIF‐1α and VEGF was observed in decidual and placental/ chorionic tissues from normal pregnancies and URPL patients, and from normal and RPL mice, but a negative correlation between the two factors was observed in the tissues from RPL mice in the presence of SalB with or without PTC299.

Conclusions

SalB ameliorates RPL by restoring physiological HIF‐1α/VEGF balance and placental angiogenesis. Optimal daily dose was 100 mg/kg, which demonstrated the absence of embryotoxicity or mitigated the embryotoxicity of RPL mice, while higher doses (400 mg/kg) showed lesser improvement and increased hepatotoxicity. The promotion of placental and decidual angiogenesis may be an effective strategy for treating unexplained RPL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoxia-Inducible Factor 1, alpha SubunitPlacentaVascular Endothelial Growth Factor AAbortion, HabitualDeciduaBenzofuransNeovascularization, PathologicAnimalsFemalePregnancyMiceHumansNeovascularization, PhysiologicAngiogenesisDepsides

Stichwörter der Autor:innen

angiogenesisanimal modelhypoxia‐inducible factor‐1αrecurrent pregnancy losssalvianolic acid Bvascular endothelial growth factor

Substanzen

Hypoxia-Inducible Factor 1, alpha Subunitsalvianolic acid BVascular Endothelial Growth Factor ABenzofuransHif1a protein, mousevascular endothelial growth factor A, mouseDepsides

Autor:innen und Institutionen

  • Reproductive Medicine Center, Department of Obstetrics and Gynecology, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
  • Reproductive Medicine Center, the Second People's Hospital of Guiyang City, Guiyang, Guizhou, China.
  • Department of Pathology, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
  • Natural Products Research Center of Guizhou Province, Guiyang, Guizhou Province, China.
  • Reproductive Immunization Center, Guangdong Provincial Reproductive Science Institute (Guangdong Provincial Fertility Hospital), NHC Key Laboratory of Male Reproduction and Genetics, Guangzhou, Guangdong, China.
  • Department of Obstetrics and Gynecology, the Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou Province, People's Republic of China.

Förderung

  • National Natural Science Foundation of China presided over by Guanyou Huang and Shuyun Zhao
  • Program of Guizhou Medical University for applying National Natural Science Foundation presided over by Guanyou Huang

Zitieren

APA

Hu, F., Yang, C., Dai, L., Gao, D., Luo, H., Zhong, X., Chen, P., Zhu, L., Xiao, Z., Zhao, S., & Huang, G. (2025). Salvianolic Acid B Promotes Placental and Decidual Angiogenesis by Restoring the Normal Expression of Hypoxia‐Inducible Factor‐1α/Vascular Endothelial Growth Factor in Mice With Recurrent Pregnancy Loss. American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.70105

Vancouver

Hu F, Yang C, Dai L, Gao D, Luo H, Zhong X, et al. Salvianolic Acid B Promotes Placental and Decidual Angiogenesis by Restoring the Normal Expression of Hypoxia‐Inducible Factor‐1α/Vascular Endothelial Growth Factor in Mice With Recurrent Pregnancy Loss. American Journal of Reproductive Immunology. 2025. doi:10.1111/aji.70105

BibTeX
@article{Hu2025,
  author = {Hu, Fangfang and Yang, Chao and Dai, Lujun and Gao, Dan and Luo, Heng and Zhong, Xingming and Chen, Panpan and Zhu, Leilei and Xiao, Ziwen and Zhao, Shuyun and Huang, Guanyou},
  title = {Salvianolic Acid B Promotes Placental and Decidual Angiogenesis by Restoring the Normal Expression of Hypoxia‐Inducible Factor‐1α/Vascular Endothelial Growth Factor in Mice With Recurrent Pregnancy Loss},
  journal = {American Journal of Reproductive Immunology},
  year = {2025},
  doi = {10.1111/aji.70105}
}
Kostenlos starten →